JPWO2020218382A1 - - Google Patents

Info

Publication number
JPWO2020218382A1
JPWO2020218382A1 JP2021516181A JP2021516181A JPWO2020218382A1 JP WO2020218382 A1 JPWO2020218382 A1 JP WO2020218382A1 JP 2021516181 A JP2021516181 A JP 2021516181A JP 2021516181 A JP2021516181 A JP 2021516181A JP WO2020218382 A1 JPWO2020218382 A1 JP WO2020218382A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021516181A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2020218382A1 publication Critical patent/JPWO2020218382A1/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/256Polyterpene radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2021516181A 2019-04-26 2020-04-22 Pending JPWO2020218382A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019086868 2019-04-26
PCT/JP2020/017402 WO2020218382A1 (fr) 2019-04-26 2020-04-22 Sécrétagogue de glp-1

Publications (1)

Publication Number Publication Date
JPWO2020218382A1 true JPWO2020218382A1 (fr) 2020-10-29

Family

ID=72941899

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021516181A Pending JPWO2020218382A1 (fr) 2019-04-26 2020-04-22

Country Status (3)

Country Link
JP (1) JPWO2020218382A1 (fr)
TW (1) TW202106308A (fr)
WO (1) WO2020218382A1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0108043A (pt) * 2000-02-01 2003-04-01 Stevia Aps Substância para uso em complementação de dieta ou para preparação de um medicamento para o tratamento de diabetes melito não-dependente de insulina, hipertensão e/ou sìndrome metabólica
SG10201912392SA (en) * 2015-07-27 2020-02-27 Suntory Holdings Ltd Composition containing cyclic dipeptide and sweetening agent
WO2017159725A1 (fr) * 2016-03-16 2017-09-21 サントリーホールディングス株式会社 Composition pour favoriser la sécrétion de glp-1, et son procédé de fabrication
EP3564251A4 (fr) * 2016-12-27 2020-12-23 Suntory Holdings Limited Nouveau glycoside de stéviol, son procédé de production et composition d'édulcorant le contenant
AU2018243332B2 (en) * 2017-03-31 2021-12-16 Suntory Holdings Limited Novel steviol glycoside and production method therefor, and sweetener composition containing same

Also Published As

Publication number Publication date
TW202106308A (zh) 2021-02-16
WO2020218382A1 (fr) 2020-10-29

Similar Documents

Publication Publication Date Title
BR112019017762A2 (fr)
BR112021017339A2 (fr)
BR112021013854A2 (fr)
BR112021017939A2 (fr)
BR112021017892A2 (fr)
BR112019016141A2 (fr)
BR112021017738A2 (fr)
BR112021017782A2 (fr)
BR112019016138A2 (fr)
BR112019016142A2 (fr)
BR112021018168A2 (fr)
BR112021017728A2 (fr)
BR112021008711A2 (fr)
BR112021017234A2 (fr)
BR112021017355A2 (fr)
BR112021017173A2 (fr)
BR112021018102A2 (fr)
BR112021017083A2 (fr)
BR112021017637A2 (fr)
BR112021012348A2 (fr)
BR112021017703A2 (fr)
BR112021013944A2 (fr)
BR112021013128A2 (fr)
BR112021017732A2 (fr)
BR112021015080A2 (fr)